Tower Research Capital (TRC)’s INVO Fertility Inc IVF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5K Buy
+8,155
New +$14.7K ﹤0.01% 3762
2026
Q1
Sell
-700
Closed -$2.63K 5674
2025
Q4
$2.63K Buy
700
+640
+1,067% +$11.2K ﹤0.01% 4492
2025
Q3
$1.83K Buy
60
+32
+114% +$2.04K ﹤0.01% 4724
2025
Q2
$2.96K Buy
28
+22
+367% +$4.59K ﹤0.01% 4572
2025
Q1
$1.48K Buy
6
+3
+100% +$1.77K ﹤0.01% 4701
2024
Q4
$3.16K Sell
3
-1
-25% -$1.2K ﹤0.01% 4700
2024
Q3
$3.62K Hold
4
﹤0.01% 4810
2024
Q2
$4.29K Sell
4
-1
-20% -$1.37K ﹤0.01% 4794
2024
Q1
$7.82K Buy
5
+2
+67% +$3.05K ﹤0.01% 4127
2023
Q4
$6.68K Buy
3
+1
+50% +$1.87K ﹤0.01% 4712
2023
Q3
$2.12K Buy
+2
New +$6.32K ﹤0.01% 5210
2023
Q2
Hold
0
5291
2023
Q1
Hold
0
4901
2022
Q4
Hold
0
5090
2022
Q3
Hold
0
4384
2022
Q2
Hold
0
4599
2022
Q1
Hold
0
4781
2021
Q4
Hold
0
-$3K 6650
2021
Q3
Hold
0
5158
2021
Q2
Hold
0
5088
2021
Q1
Hold
0
4937

Other funds holding IVF

Tower Research Capital (TRC)'s IVF Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in INVO Fertility Inc (IVF) in Q2 2026: 8,155 shares worth $15.5K. The stake represents ﹤0.01% of the portfolio and ranks #3762 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in IVF as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in IVF in Q3 2023 and has held it in 11 quarters since. 10 funds tracked by Wall St. Rank hold IVF as of Q2 2026.

  • Tower Research Capital (TRC) held 8,155 shares of INVO Fertility Inc worth $15.5K as of Q2 2026.
  • INVO Fertility Inc was a new Tower Research Capital (TRC) position in Q2 2026.
  • INVO Fertility Inc made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3762 holding.
  • Tower Research Capital (TRC) first reported a position in INVO Fertility Inc in Q3 2023 and has held it in 11 quarters since.
  • 10 funds tracked by Wall St. Rank held INVO Fertility Inc as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.